Diagnostic Molecular Pathology in Practice

Iris Schrijver, MD, initially studied at the University of Utrecht in The Netherlands. She gained her board certification in Clinical Molecular Genetics from the American Board of Medical Genetics and subsequently served her residency in Clinical Pathology at Stanford University. Dr. Schrijver gained her board certification in Clinical Pathology from the American Board of Pathology. Since 2003, she has been Director of the Molecular Pathology Laboratory at Stanford University Medical Center and Lucile Packard Children's Hospital. She is an Associate Professor at the University, Director of the Stanford MGP fellowship program, and Associate Director of the residency program in Clinical Pathology. She has been the lead author or a co-author on 57 publications in peer-reviewed journals.

Cystic Fibrosis.- Alport Syndrome.- Alpha Thalassemia.- Charcot-Marie-Tooth Disease.- Hearing Loss.- Polycystic Kidney Disease.- Fragile X Syndrome.- Malignant Hyperthermia.- Rh Incompatibility.- Pharmacogenetics.- B Cell Lymphoma.- T Cell Lymphoma.- Post-Transplant Lymphoproliferative Disorder.- HIV-Associated Hodgkin Lymphoma.- Chronic Myelogenous Leukemia.- Myeloproliferative Neoplasms.- Acute Myeloid Leukemia: FLT3 and NPM1.- Acute Myeloid Leukemia: CEBPA.- Bone Marrow Engraftment Analysis.- Mixed Phenotype Acute Leukemia.- Breast Cancer.- Lung Adenocarcinoma.- Melanoma.- Thyroid Cancer.- Renal Cell Carcinoma.- Gastrointestinal Stromal Tumor.- Lynch syndrome.- Oligodendroglioma.- Glioblastoma Multiforme.- Carcinoma Of Unknown Primary.- Human Immunodeficiency Virus.- Cytomegalovirus.- Human Papillomavirus.- Chlamydia trachomatis.- MRSA.- Influenza A (H1N1).- Bordetella pertussis.- Human Metapneumovirus.- BK Virus.- Respiratory Viruses.